Identifying biomarkers to predict healing in diabetic foot ulcers
Proteomic Biomarkers Prognostic for Diabetic Wound Healing
This study is looking at certain proteins in the blood to see if they can help predict how well diabetic foot ulcers will heal, so that doctors can better tailor treatments for patients who might struggle with healing.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Beth Israel Deaconess Medical Center NIH-funded |
| Lab location | 1 site (Boston, United States) |
| Project ID | NIH-11159350 on NIH RePORTER |
What this research studies
This research investigates the use of specific proteins in the blood to predict how well diabetic foot ulcers will heal. By analyzing these proteins, researchers aim to identify patients who are at higher risk for poor healing outcomes. The study employs advanced statistical and machine learning techniques to develop a multi-biomarker panel that can provide a more accurate prognosis for wound healing. This approach could lead to personalized treatment strategies for patients with diabetic foot ulcers.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals with diabetes who are at risk of developing foot ulcers or have existing diabetic foot ulcers.
Not a fit: Patients without diabetes or those who do not have diabetic foot ulcers may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved healing outcomes for patients with diabetic foot ulcers by enabling targeted interventions.
How similar studies have performed: Previous research has shown promise in using biomarker panels for predicting healing outcomes in various conditions, suggesting that this approach may be effective for diabetic foot ulcers as well.
Where this research is happening
Boston, United States
- Beth Israel Deaconess Medical Center — Boston, United States (Active)
Researchers
- Principal investigator: Veves, Aristidis — Beth Israel Deaconess Medical Center
- Study coordinator: Veves, Aristidis
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.